by Steve Oconnor | Apr 18, 2020 | Shift News Updates
CMT Research Foundation funds Shift to explore novel series of drugs created to control the expression of PMP22 gene Overland Park: In late January, the CMT Research Foundation (CMTRF) announced a partnership with Shift Pharmaceuticals to further research in...
